(Q40869861)

English

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

scientific article published on July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways (English)

1 reference

Europe PubMed Central

24 September 2017

2

1 reference

Europe PubMed Central

24 September 2017

author name string

Plonowski A

1

1 reference

Europe PubMed Central

24 September 2017

Varga JL

3

1 reference

Europe PubMed Central

24 September 2017

Rekasi Z

4

1 reference

Europe PubMed Central

24 September 2017

Hebert F

5

1 reference

Europe PubMed Central

24 September 2017

Halmos G

6

1 reference

Europe PubMed Central

24 September 2017

Groot K

7

1 reference

Europe PubMed Central

24 September 2017

publication date

1 July 2000

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

44

1 reference

Europe PubMed Central

24 September 2017

2

1 reference

Europe PubMed Central

24 September 2017

172-180

1 reference

Europe PubMed Central

24 September 2017

In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Peptide growth factors and prostate cancer: new models, new opportunities

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH).

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Mechanistic concepts in androgen-dependence of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Vasoactive intestinal peptide (VIP)1 receptor. Three nonadjacent amino acids are responsible for species selectivity with respect to recognition of peptide histidine isoleucineamide.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Molecular and cell biology of the growth hormone-releasing hormone receptor

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Activation of the human androgen receptor through a protein kinase A signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-cleavage enzyme, P450scc [corrected], in human steroidogenic tissues

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Developmental and hormonal regulation of mRNAs for insulin-like growth factor II and steroidogenic enzymes in human fetal adrenals and gonads

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

cAMP production by GHRH in GH-producing pituitary adenoma cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway

1 reference

https://api.crossref.org/works/10.1002%2F1097-0045%2820000701%2944%3A2%3C172%3A%3AAID-PROS10%3E3.0.CO%3B2-Z

21 January 2018

G protein-coupled receptors and signaling pathways regulating growth responses.

0 references

Identifiers

10.1002/1097-0045(20000701)44:2<172::AID-PROS10>3.0.CO;2-Z

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40869861&oldid=1909363521"